Digital Pathology – Page 2

ContextVision announces signed contract with Vall d’Hebron for clinical evaluation of INIFY® Prostate Screening

ContextVision, Digital Pathology, Home, Investor News, News, OEM 2021-02-11

INIFY® Prostate Screening is a powerful AI-based software that predicts, outlines and quantifies suspicious cancerous areas in a series of prostate biopsies.

An AI-based tool to identify cancer areas in lung biopsies

Digital Pathology, In The Media 2020-12-05

An AI-based tool to identify cancer areas in lung biopsies

Diagnosing Cancer With Confidence

Digital Pathology, In The Media 2020-11-10

Diagnosing Cancer With Confidence How bringing AI into the laboratory workflow can benefit both pathologist and patient

ContextVision podcast: How is AI revolutionizing digital pathology?

ContextVision, Digital Pathology, Home, News, Podcast 2020-07-01

ContextVision just launched the company’s first CE marked digital pathology product based on artificial intelligence. In this podcast the company’s CEO Fredrik Palm and Dr. Filippo Fraggetta, the chief pathologist at the Cannizzaro Hospital, will talk about the revolution we are approaching within digital pathology. Listen here

ContextVision announces first CE marked digital pathology product

ContextVision, Digital Pathology, Home, Investor News, News 2020-06-29

ContextVision today announced that its first digital pathology product in a planned portfolio has been granted CE mark status. This means that INIFY® Prostate Screening is now available for routine clinical use within the European Union.

Clinical‑grade Computational Pathology: Alea Iacta Est

Digital Pathology, In The Media 2019-12-11

Filippo Fraggetta: Clinical‑grade Computational Pathology: Alea Iacta Est

ContextVision announces first digital pathology patent granted for its unique and objective data-generation method

ContextVision, Digital Pathology, Home, Investor News, News 2019-11-21

Master Annotation method has received patent protection in the U.S. The U.S. Patent and Trademark Office (USPTO) has granted a patent to ContextVision for this invention, titled “method and system for detecting pathological anomalies in a digital pathology image and method for annotating a tissue slide”.

Meet us at the 31st European Congress of Pathology in Nice (ECP 2019), 7–11 September 2019

Digital Pathology, Invitations 2019-06-13

Come and talk to our representatives about our upcoming digital pathology portfolio.

ContextVision’s Deep Learning experts will hold an oral presentation at the Medical Imaging & Deep Learning conference in London July 8–10

Digital Pathology, Home, News 2019-06-12

This paper presents an interesting and novel idea of a deep learning (DL) framework to segment potentially cancerous areas in prostate biopsies using semi-automatically generated data. The application of this paper is quite innovative and the proposed method seems to be a direct assistance to the clinical routine.

Frost & Sullivan recognises the Stockholm-based ContextVision AB with the 2019 European Technology Leadership Award for its INIFY™ Prostate platform.

ContextVision Earns Acclaim from Frost & Sullivan for Its AI-powered INIFY™ Prostate Cancer Screening Platform

Digital Pathology, Investor News, News 2019-04-02

Based on its recent analysis of the European prostate cancer screening market, Frost & Sullivan recognises the Stockholm-based ContextVision AB with the 2019 European Technology Leadership Award for its INIFY™ Prostate platform.